Michalski Huettermann Patent Attorneys, Duesseldorf, Germany.
MAbs. 2011 Nov-Dec;3(6):596-606. doi: 10.4161/mabs.3.6.17788. Epub 2011 Nov 1.
Therapeutic antibodies need international patent protection as their markets expand to include industrialized and emerging countries. Because international intellectual property strategies are frequently complex and costly, applicants require sound information as a basis for decisions regarding the countries in which to pursue patents. While the most important factor is the size of a given market, other factors should also be considered.
治疗性抗体需要国际专利保护，因为它们的市场扩大到包括工业化国家和新兴国家。由于国际知识产权战略常常很复杂且代价高昂，申请人需要可靠的信息作为在哪些国家申请专利的决策依据。虽然最重要的因素是特定市场的规模，但也应考虑其他因素。
